Report ID: 10294061 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
REPORT HIGHLIGHT
The calcifediol monohydrate acid was valued at USD 31,800 thousand by 2017, growing with 5.4% CAGR during the forecast period, 2018-2025.
Calcifediol monohydrate (25-Hydroxyvitamin D3) is a prehormone or vitamin D3 analogue, which is produced by hydroxylation of vitamin D3 (cholecalciferol) through the utilization of enzyme cholecalciferol 25-hydroxylase. Rising spending on Advanced Pharmaceutical Ingredients (API) manufacturing in the emrging economies including, China and India is projected to remain a favorable factor for the Calcifediol monohydrate market. For instance, investment in production of vitamin D analogues is likely to remain a key trend on account of their increasing visibility as an ingredient with good gene regulatory properties. For instance, Dishman Group owned a vitamin D analogue manufacturing facility in the Netherlands in 2017. The company is planning to expand the production capacity of vitamin D analogues including, calcifediol monohydrate in India in order to cater the growing demand from animal feed and pharma sectors.
Furthermore, rising prevalance of chronic kidney disese (CKD) on a global level as a result of fluctuating diet patterns and hectic workstyle is driving the growth of calcifediol monohydrate-based drugs. For instance, according to National Center for Chronic Disease Prevention and Health Promotion (USA), around 15% of the total U.S. population is suffering from chronic kidney disease (CKD).
In addition, rising prevalence of rickets and osteomalacia is expected to provide growth opportunity for this industry. For instance, according to The Centers for Disease Control and Prevention, 5 per 1,000,000 children aged between 6 months and 5 years have rickets. On contrary, the production of this chemical involves technological advanced machinery owing to its high concentration and purity of vitamin D, hampering the market growth to some extent.
Application Takeaway
Global calcifediol monohydrate market is segmented on the basis of three application segments including, animal feed, pharmaceutical, and others. Others application segment covers the use of calcifediol monohydrate in personal care and nutraceutical applications. Among animal industry, species such as broilers, cattle, breeders, and swine are expected to use calcifediol monohydrate as a key source for the calcium and phosphorus absorption in the body and mobilisation of calcium in bones. In addition, it also helps in improving the immune cells.
Regional Takeaway
Asia Pacific is accounted for the largest market, accounting for over 50% of global calcifediol monohydrate market. In the region, animal feed accounted for 95% of the produced volume of calcifediol monohydrate. Increasing production of livestock in the region is expected to fuel the demand for animal feed. Europe is considered to be the second largest consumer of calcifediol monohydrate. The region is expected to witness a high growth rate on account of rising prevalence of kidney disorders.
Key Vendors Takeaway
Dishman Group
Chemvon Biotechnology Co
Haoyuan Chemexpress Co., Ltd
Pharmaceutical Research Institute (PRI)
Companies are actively engaged in research and development activities. Major manufacturers of vitamin D and vitamin D2 including Chemvon Biotechnology, and Dishman Group owned technology to produce the calcifediol. In addition, it is noted that key manufacturers are installing their manufacturing facilities in the Europe due to the favorable regulations regarding manufacturing and marketing of Vitamin D analogues and Vitamin D3 APIs.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year – 2014 & 2016
Base Year – 2017
Estimated Year – 2018
Projected Year – 2025
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY APPLICATION
Animal Feed
Pharmaceutical
Others
MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10294061 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
